[1]
GhavamiM., HoushyarJ., MehdizadehA., NajafipourM., and NajafipourF., “Effective Reduction of Inflammatory and Coagulation Factors using Sitagliptin in Type 2 Diabetes ”, Iran. Red. Crescent. Med. J., vol. 23, no. 3, Mar. 2021.